AMBRISENTAN
These highlights do not include all the information needed to use AMBRISENTAN TABLETS safely and effectively. See full prescribing information for AMBRISENTAN TABLETS. AMBRISENTAN Tablets, for oral use Initial U.S. Approval: 2007
e20ab2fe-bc9f-48a3-b15a-e4bc9532c2ac
HUMAN PRESCRIPTION DRUG LABEL
Jan 10, 2023
Sigmapharm Laboratories, LLC
DUNS: 556234636
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
AMBRISENTAN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
AMBRISENTAN
Product Details
FDA regulatory identification and product classification information